• About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: AAN 2015

Use of high-efficacy agents in MS: Updated data from AAN 2015

June 3, 2015  

Efficacy and effectiveness of first-line oral medications in MS

May 21, 2015  

Endovascular trials in ischemic stroke: an update

April 24, 2015  

MS therapies: longer-term results

April 24, 2015  

Anti-LINGO-1 MAb in optic neuritis: RENEW results

April 24, 2015  

Comorbidities common in MS

April 23, 2015  

TARGET trial of intranasal sumatriptan

April 23, 2015  

NEDA-4 – an update

April 23, 2015  

Levodopa-carbidopa intestinal gel: updated GLORIA results

April 22, 2015  

After natalizumab: what are the options?

April 22, 2015  
1
2

Browse by Topic

MS (268)
AD (81)
PD (77)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
MIGRAINE (26)
SCHIZOPHRENIA (25)
STROKE (22)
EPILEPSY (21)
COVID-19 (16)
ECTRIMS 2015 (13)
AAN 2015 (11)
ECTRIMS 2014 (10)
DEMENTIA (10)
ECTRIMS 2018 (10)
ECTRIMS 2019 (10)
ECTRIMS 2013 (9)
AAN 2014 (9)
MS SEQUENCING (9)
AAN 2013 (9)
PSYCHIATRY (8)
AAN 2019 (7)
ACTRIMS-ECTRIMS 2020 (7)
ECTRIMS 2017 (7)
ECTRIMS 2016 (6)
CHARCOT 2013 (6)
CCSVI (5)
BIPOLAR (5)
ANXIETY (5)
AAN 2017 (4)
EAN 2015 (4)
BPD (4)
NeuroSound (4)
AAN 2018 (3)
PAIN (3)
ENS 2013 (3)
AAN 2020 (3)
APA 2014 (2)
EAN 2020 (2)
SPECIAL REPORT (2)
SLEEP (2)
NEW DRUGS (2)
AAN 2016 (2)
ADDICTION (1)
EAN 2019 (1)
LUMBAR PUNCTURE (1)
CONCUSSION (1)
CIDP (1)
Dravet syndrome (1)
hATTR (1)
ALS (1)
SEIZURE (1)
INSOMNIA (1)
WEST NILE (1)
LGS (1)
APA 2016 (1)
EAN 2016 (1)
GUIDELINES (1)
TSC (1)
ECTRIMS 2020 (0)
View all Topics

Popular Posts

  • Multiple sclerosis 2021 – a look ahead posted on January 13, 2021
  • Progression independent of relapses (PIRA) in MS posted on November 21, 2019
  • Ozanimod vs. fingolimod: is there a difference? posted on November 13, 2020
Copyright 2021 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions